Sikkert Vægttab

Clinic prescribes, any Danish pharmacy dispenses or an approved online pharmacy fulfils. Payment before the clinical gate.

299 DKK every four weeks, with the drug stated as typically 855 to 4,500 DKK a month depending on product and dose. Offers a money-back guarantee if the patient has not lost weight after three months, which sits uneasily with the regulator’s list of prohibited consumption-stimulating techniques.

None disclosed.

10 employees per the register, FY2025 gross profit 1.67m DKK, net 37k DKK, equity 173k DKK. 122 Trustpilot reviews at 4.6, the lowest score of the four largest Danish clinics. The headcount is hard to reconcile with the gross profit, since Danish bruttofortjeneste is struck before staff costs, and that is recorded unresolved.

The naming leader in the Nordics at 74 brand-named sitemap URLs. It also runs waiting-list pages for Foundayo (orforglipron) and an oral Wegovy while stating on the same pages that neither pill is yet available in Denmark. Lægemiddelloven §64 no. 1 prohibits advertising medicines that cannot lawfully be sold in Denmark, so the factual predicate sits on their own page in their own words.

Its right-of-withdrawal clause is unusually aggressive: if time and resources have been spent starting a patient, the statutory cancellation right is said not to apply.